The tumor growth status was monitored for 4 to 5 weeks, in which the mice received two injections of IFN-γ, (the experimental group was intraperitoneally injected with 10 μg of IFN-γ in 200 mL of medium one time per day for two consecutive days; PBS was used in control group). This evidence concerns the gene IFNG and neoplasm.